LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 192 filers reported holding LEGEND BIOTECH CORP in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,463,608 | -4.6% | 81,340 | -1.9% | 0.01% | 0.0% |
| Q2 2023 | $5,724,105 | +61.0% | 82,922 | +12.5% | 0.01% | +50.0% |
| Q1 2023 | $3,554,730 | +10.4% | 73,719 | +14.3% | 0.00% | +33.3% |
| Q4 2022 | $3,219,391 | +13.4% | 64,491 | -7.3% | 0.00% | 0.0% |
| Q3 2022 | $2,839,000 | -55.5% | 69,591 | -40.0% | 0.00% | -57.1% |
| Q2 2022 | $6,385,000 | +29.2% | 116,079 | -14.6% | 0.01% | +75.0% |
| Q1 2022 | $4,941,000 | -3.5% | 135,978 | +23.8% | 0.00% | +33.3% |
| Q4 2021 | $5,119,000 | +500.8% | 109,824 | +552.0% | 0.00% | – |
| Q3 2021 | $852,000 | +44.4% | 16,843 | +17.2% | 0.00% | – |
| Q2 2021 | $590,000 | +23.4% | 14,377 | -12.8% | 0.00% | – |
| Q1 2021 | $478,000 | +28.8% | 16,493 | +25.2% | 0.00% | – |
| Q4 2020 | $371,000 | – | 13,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |